Skip to main content

Advertisement

SpringerLink
Log in

Safety of not withholding clopidogrel therapy during the immediate several days pre- and post-trans-urethral resection of prostate (TURP): a retrospective cohort study

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background and aim

Benign prostatic hypertrophy or hyperplasia (BPH) is a frequent urological complain particularly in old-aged individuals. Those patients usually have other risk factors (such as ischemic cardiovascular diseases) for which they might be treated with anti-thrombotic agents chronically. These medicines may induce blood thinning and raise the incidence of hemorrhage. Thus, if those patients needed operative treatment for BPH, they may be at high risk of hemorrhage or its related adverse effects with the usage of anti-thrombotic drugs during the peri-operative time. On the other hand, dis-continuation of these agents can lead to ischemic events in susceptible individuals.

Therefore, this research aims to assess the safety of the continuation of using anti-thrombotic agents throughout the peri-operative duration in patients with prostate surgery in form of Transurethral Resection of Prostate (TURP) only for Benign Prostatic Hypertrophy (BPH).

Methods

Patients’ notes were reviewed retrospectively. The entire participants were categorized into two categories. First category was on clopidogrel therapy (CTC) for prolong time and the usage of these agents was carried on throughout the peri-operative period. The second category was not on clopidogrel therapy at all (NCTC). Both of these categories had Transurethral Resection of Prostate (TURP) for Benign Prostatic Hypertrophy (BPH). A comparison had been conducted between the two categories with regards to: (i) the amount of blood lost intra-operatively (ii) the duration of operation (iii) hematocrit concentration per-operatively (iv) transfused packed red blood cells (PRBC) if needed (v) clearance of hematuria postoperatively (vi) secondary hemorrhage and clot retention after discharge. Pearson Chi-square test, Independent sample t test and test for numeric variables were used as appropriate.

Results

The study identified 329 patients. One hundred and sixty five participants in the CTC (clopidogrel therapy category) and 164 in the NCTC (non-clopidogrel therapy category). It had been revealed that there was no statistically significant difference between the CTC and NCTC regarding: (i) the amount of blood lost intra-operatively (ii) the duration of operation (iii) hematocrit concentration per-operatively (iv) transfused packed red blood cells (packed RBC) if needed (v) clearance of hematuria postoperatively (vi) secondary hemorrhage and clot retention after discharge (P > 0.65).

Conclusion

The continuation of usage of anti-thrombotic therapy (clopidogrel) during peri-operative period in patients with TURP for BPH is a safe practice. It is not associated with high probability of hemorrhage or PRBC transfusion or other adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Choi YD, Ham WS, Kim WT, Yang WJ, Koo KC, Ju HJ (2009) Outcome of urologic surgeries in the patients continuing antiplatelet drugs. J Urol 181:463

    Article  Google Scholar 

  2. Donat R, Wilson I, Raza A, Byrne DJ, Smith G, Stewart LH (2003) A multicentre prospective, randomised, doubleblind placebo-controlled trial of aspirin during transurethral resection of the prostate (TURP). J Urol 169:466–467

    Google Scholar 

  3. Eberli D, Chassot PG, Sulser T et al (2010) Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 183:2128–2136

    Article  Google Scholar 

  4. Enver MK, Hoh I, Chinegwundoh F (2006) The management of aspirin in transurethral prostatectomy: current practice in the UK. Ann R Coll Surg Engl 88:280–283

    Article  Google Scholar 

  5. Mukerji G, Munasinghe I, Raza A (2009) A survey of the peri-operative management of urological patients on clopidogrel. Ann R Coll Surg Engl 91:313–320

    Article  Google Scholar 

  6. Descazeaud A, Robert G, Lebdai S, Bougault A, Azzousi R, Haillot O et al (2011) Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol 29:211–216

    Article  CAS  Google Scholar 

  7. Becker B, Knipper S, Gross AJ, Netsch C (2017) Current management in transurethral therapy of benign prostatic obstruction in patients on oral anticoagulation: a worldwide questionnaire. J Endourol 31:163–168

    Article  Google Scholar 

  8. Thurston AV, Briant SL (1993) Aspirin and post-prostatectomy haemorrhage. Br J Urol 71:874

    Google Scholar 

  9. Biondi-Zoccai GG, Lotrionte M, Agostoni P et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674

    Article  Google Scholar 

  10. Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Int Med 2(57):399–414

    Article  Google Scholar 

  11. Shahar E, Folsom AR, Romm FJ et al (1996) Patterns of aspirin use in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Am Heart J 131:915–922

    Article  CAS  Google Scholar 

  12. Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, Pastor-Barriuso R, Sharrett AR, Faraday N (2009) Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med 169(8):788–796

    Article  Google Scholar 

  13. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA et al (2003) Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med 28(3):172–197

    PubMed  Google Scholar 

  14. Vasudeva P, Goel A, Sengottayan VK, Sankhwar S, Dalela D (2009) Antiplatelet drugs and the perioperative period: what every urologist needs to know. Indian J Urol 25:296–301

    Article  Google Scholar 

  15. Shiga T, Wajima Z (2008) Ohe Y Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth 55(3):146–154

    Article  Google Scholar 

  16. Sun J, Shi A, Tong Z, Xue W (2018) Safety and feasibility study of holmium laser enucleation of the prostate (HOLEP) on patients receiving dual antiplatelet therapy (DAPT). World J Urol 36:271–276

    Article  Google Scholar 

  17. Taylor K, Filgate R, Guo DY, Macneil F (2011) A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs. BJU Int 108(Suppl 2):45–50

    Article  Google Scholar 

  18. Oh SJ (2019) Current surgical techniques of enucleation in holmium laser enucleation of the prostate. Investig Clin Urol 60:333–342

    Article  Google Scholar 

  19. Malaeb BS, Yu X, McBean AM, Elliott SP (2012) National trends in surgicaltherapy for benign prostatic hyperplasia in the United States (2000–2008). Urol 79:1111–1116

    Article  Google Scholar 

  20. Feigin VL et al (2014) Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet 383:245–254

    Article  Google Scholar 

  21. Netsch C, Moritz C (2016) Current practice in the transurethral treatment of benign prostatic obstruction under oral anticoagulants: a nation-wide survey. Urol A 55(6):792–800

    Article  Google Scholar 

  22. Becker B, Knipper S, Gross AJ, Netsch C (2017) Current management in transurethral therapy of benign prostatic obstruction in patients on oral anticoagulation: a worldwide questionnaire. J Endourol 31(2):163

    Article  Google Scholar 

  23. Tamhankar AS, Patil SR, Ahluwalia P, Gautam G (2018) Does continuation of low-dose aspirin during robot-assisted radical prostatectomy compromise surgical outcomes? J Endourol 32(9):852–858

    Article  Google Scholar 

  24. Binhas M, Salomon L, Roudot-Thoraval F, Armand C, Plaud B, Marty J, Prostatectomy R-A, Loss L-D (2012) Radical prostatectomy with robot-assisted radical prostatectomy and laparoscopic radical prostatectomy under low-dose aspirin does not significantly increase blood loss. Urology 79(3):591–595

    Article  Google Scholar 

  25. Yuk HD, Oh SJ (2020) Perioperative safety and efficacy of holmium laser enucleation of the prostate in patients receiving antithrombotic therapy: a prospective cohort study. Sci Rep 10(1):5308

    Article  CAS  Google Scholar 

  26. Carneiro A, Cha JD, Baccaglini W, Husain FZ, Wroclawski ML, Nunes-Silva I, Sanchez-Salas R, Ingels A, Kayano PP, Claros OR, Saviano Moran NK (2019) Should aspirin be suspended prior to robot-assisted radical prostatectomy? A systematic review and meta-analysis. Ther Adv Urol 11:1–12

    Article  Google Scholar 

  27. Rühle A, Blarer J, Oehme F, Marini L, Mattei A, Stucki P, Danuser H (2019) Safety and effectiveness of bipolar transurethral resection of the prostate in patients under ongoing oral anticoagulation with coumarins or antiplatelet drug therapy compared to patients without anticoagulation/antiplatelet therapy. J Endourol. https://doi.org/10.1089/end.2018.087

    Article  PubMed  Google Scholar 

  28. Hochreiter WW, Thalmann GN, Burkhard FC, Studer UE (2002) Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 168:1470–1474

    Article  Google Scholar 

  29. Bolton DM, Costello AJ (1994) Management of benign prostatic hyperplasia by transurethral laser ablation in patients treated with warfarin anticoagulation. J Urol 151:79–81

    Article  CAS  Google Scholar 

  30. Descazeaud A et al (2011) Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol 29:211–216

    Article  CAS  Google Scholar 

  31. Elzayat E, Habib E, Elhilali M (2006) Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol 175:1428–1432

    Article  CAS  Google Scholar 

  32. Marchioni M et al (2018) Perioperative major acute cardiovascular events after 180-W GreenLight laser photoselective vaporization of the prostate. Int Urol Nephrol 50:1955–1962

    Article  CAS  Google Scholar 

  33. Raj MD et al (2011) Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications. Urol 78:1380–1384

    Article  Google Scholar 

Download references

Acknowledgements

The participants and our institutions.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Surgery, College of Medicine, University of Kerbala, Kerbala, Iraq

    Ahmed Kamel Abdulhamid

  2. Al-Imam Al-Hussein Medical City, Kerbala Health Directorate, Kerbala, Iraq

    Rusul Jasim Khalaf

Authors
  1. Ahmed Kamel Abdulhamid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rusul Jasim Khalaf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed Kamel Abdulhamid.

Ethics declarations

Conflict of interest

None.

Informed consent

Done. The research involved human participants who were contacted and their consent for the study had been taken.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdulhamid, A.K., Khalaf, R.J. Safety of not withholding clopidogrel therapy during the immediate several days pre- and post-trans-urethral resection of prostate (TURP): a retrospective cohort study. Int Urol Nephrol 54, 985–992 (2022). https://doi.org/10.1007/s11255-022-03147-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-022-03147-y

Keywords

Search

Navigation